Healthcare
12 companies · Q2FY27
Read 6.6ConcallScore —Trailing 7.3Growth 6.9Valuation 3.6
rating label | latest | 4Q avg | forward | higher = cheaper | the three, combined | ||
|---|---|---|---|---|---|---|---|
| 1 | Hospital | Narrow MoatMid | — | 8.0Bullish | 7.1Solid | 7.5Undervalued | 7.5Aligned & cheap |
| 2 | Pharmaceuticals | Narrow MoatWeak | — | 7.6Bullish | 7.6Strong | 5.5Fair | 7.4Quality at a fair price |
| 3 | Pharmaceuticals | No MoatWeak | — | 6.5Mildly Bullish | 8.4Exceptional | — | 7.0Outlook-led |
| 4 | Pharmaceuticals | No MoatWeak | — | 7.3Bullish | 7.2Strong | 3.9Expensive | 6.9Priced for it |
| 5 | Medical Equipment & Supplies | No MoatWeak | — | 7.2Bullish | 6.8Solid | — | 6.8No price read |
| 6 | Pharma Distribution | No MoatWeak | — | 7.3Bullish | 6.6Solid | 4.7Fair | 6.7Quality at a fair price |
| 7 | API & CDMO | No MoatWeak | — | 7.8Bullish | 7.0Solid | 0.0Richly priced | 6.5Priced for it |
| 8 | API & CDMO | No MoatWeak | — | 7.4Bullish | 5.9Moderate | — | 6.4Peaking |
| 9 | Pharmaceuticals | No MoatWeak | — | 6.7Mildly Bullish | 6.9Solid | 3.0Expensive | 6.3Priced ahead of it |
| 10 | Pharmaceuticals | Narrow MoatMid | — | 7.2Bullish | 6.0Moderate | 4.0Fair | 6.3Peaking |
| 11 | API & CDMO | Narrow MoatMid | — | 7.1Bullish | 6.3Moderate | 2.4Expensive | 6.3Peaking |
| 12 | API & CDMO | No MoatWeak | — | 7.3Bullish | 6.5Solid | 1.2Richly priced | 6.2Priced for it |